Company profile
AdvanCell
Changing the Course of Cancer Treatment
- Industry
- Biotechnology Research
- Employees
- 93
- Headquarters
- Boston , Massachusetts
- Founded
- 2019
- LinkedIn followers
- 8,890
- Office locations
- 6
AdvanCell company summary
AdvanCell is a company in the Biotechnology Research industry, headquartered in Boston , Massachusetts, founded in 2019. On LinkedIn the company has around 93 employees and 8,890 followers. The company lists 6 office locations. Its listed specialties include Radiopharmaceuticals, Radioligand Discovery, 212Pb, Biotechnology, Biopharmaceuticals.
What technology does AdvanCell use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About AdvanCell
AdvanCell is a clinical stage radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the most significant challenge in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell’s novel drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212Pb, the ideal isotope for Targeted Alpha Therapy. For more information, please visit www.advancell.com.au
Specialties
Where is AdvanCell located?
AdvanCell lists 6 office locations.
Compare companies similar to AdvanCell
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
AdvanCell advancell.com.au | Biotechnology Research | 93 | 2019 | Boston , Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about AdvanCell
What does AdvanCell do?
AdvanCell is a clinical stage radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the most significant challenge in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell’s novel drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212Pb, the ideal isotope for Targeted Alpha Therapy. For more information, please visit www.advancell.com.au
How many employees does AdvanCell have?
AdvanCell has around 93 employees on LinkedIn.
Where is AdvanCell headquartered?
AdvanCell is headquartered in Boston , Massachusetts.
Where does AdvanCell have offices?
AdvanCell lists 6 office locations, including Boston, Massachusetts, US; Newcastle, NSW, AU; Pullenvale, AU, AU; Richlands, Queensland, AU; SAN FRANCSICO, CA, US.
When was AdvanCell founded?
AdvanCell was founded in 2019.
Build a lead list from companies like AdvanCell
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.